Asian Journal of Urology (Jul 2019)

Safety and feasibility of thullium laser transurethral resection of prostate for the treatment of benign prostatic enlargement in overweight patients

  • Luca Carmignani,
  • Maria Chiara Clementi,
  • Claudia Signorini,
  • Gloria Motta,
  • Sebastiano Nazzani,
  • Franco Palmisano,
  • Elisa De Lorenzis,
  • Michele Catellani,
  • Alessandro Francesco Mistretta,
  • Andrea Conti,
  • Valeria Tringali,
  • Maria Beatrice Costa,
  • Damiano Vizziello

Journal volume & issue
Vol. 6, no. 3
pp. 270 – 274

Abstract

Read online

Objective: We aimed to determine safety and feasibility of thulium laser transurethral vapoenucleation of prostate (ThuVEP) for treatment of obese patients affected by benign prostatic hyperplasia (BPH). Methods: We retrospectively analysed data of 452 patients with BPH who underwent ThuVEP from February 2012 to March 2016 in a single center. Patients were divided into three groups according to body mass index (BMI, kg/m2): Normal weight (18.5 ≤ BMI 0.05). There was no statistically significant difference among three groups as for hospital stay and days of catheterization (p > 0.05). Conclusion: Our results showed that ThuVEP was safe and feasible even in overweight patients with substantially enlarged prostate. Keywords: Laser, Thulium, Prostate, Overweight